Countries Europe

Alnylam and Medison Pharma expand RNAi Therapeutics Partnership

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma co...

 March 09, 2023 | News

IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...

 March 09, 2023 | News

Virax Biolabs Introduces Avian Influenza PCR Test Kit

The test kit is for use in laboratory settings and can help healthcare professionals accurately identify an AIV infection. It also serves as a valuable ini...

 March 09, 2023 | News

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules

“We are thrilled to offer this cutting-edge technology to the research community,” says Jos Joore, co-CEO of MIMETAS. “We&rsquo...

 March 08, 2023 | News

Abacus Medicine Pharma Services and AddMedica Sign Partnership Agreement for the Distribution of Siklos® in Benelux

Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...

 March 07, 2023 | News

Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance

 Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...

 March 07, 2023 | News

Hummingbird Bioscience licenses Cancer Research UK's clinical trial results to support HMBD-001 development.

The Phase 1/2a clinical trial in the United Kingdom is being sponsored and managed by CRUK's Centre for Drug Development and led by Chief Investi...

 March 06, 2023 | News

Harbour BioMed's Batoclimab Shows Positive Results in Phase III Trial for Myasthenia Gravis

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...

 March 06, 2023 | News

Prenetics Forms Advisory Board for Precision Oncology Strategy

Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Adviso...

 March 02, 2023 | News

ClinChoice Acquires CROMSOURCE, Expanding its Global Presence

Founded in 1997, CROMSOURCE has a proven track record of supporting global pharmaceutical, biotechnology, and medical device clients with exceptional clini...

 March 02, 2023 | News

Clean Cells launches activities at new biopharmaceutical quality control facility - largest in Europe

Company anticipates strong growth in demand and activity, focusing on new treatments such as cell and gene therapies, and offering new and improved service...

 March 01, 2023 | News

"Anura™ contactless health monitoring tech to integrate with mobile devices

Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...

 February 27, 2023 | News

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SN514 hydrogel is a topical debridement product designed to remove eschar rapidly and effectively from severe burn wounds and chronic ulcers, including p...

 February 24, 2023 | News

Lunit to Establish Subsidiary in Europe to Accelerate Business Expansion

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer solutions, today announced its decision to establish a new subsidiary, Lunit Europe Holdings,...

 February 18, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close